Intervention | Fractures risk | Falls risk | Number of fractures | Number of falls | ||||
N (%) improved | P value | N (%) improved | P value | N (%) improved | P value | N (%) improved | P value | |
Exercise programmes (n=99) | ||||||||
Adherent (n=40) | 13 (33%) | 0.65 | 30 (77%) | 0.03 | 18 (45%) | 1.00 | 37 (93%) | 0.006 |
Non-adherent (n=59) | 16 (27%) | 32 (54%) | 25 (43%) | 41 (69%) | ||||
Vitamin D/calcium (n=100) | ||||||||
Adherent (n=85) | 27 (32%) | 0.06 | 54 (64%) | 0.57 | 38 (45%) | 0.57 | 65 (76%) | 0.18 |
Non-adherent (n=15) | 1 (7%) | 11 (73%) | 5 (33%)1 | 14 (93%) | ||||
Osteoporosis medications (n=66) | ||||||||
Adherent (n=48) | 22 (46%) | 0.01 | 34 (71%) | 0.14 | 29 (60%) | 0.56 | 38 (79%) | 1.00 |
Non-adherent (n=18) | 2 (12%) | 8 (47%) | 12 (71%) | 15 (83%) | ||||
Medication changes (n=69) | ||||||||
Adherent (n=44) | 14 (32%) | 0.40 | 28 (64%) | 1.00 | 16 (36%) | 0.04 | 32 (73%) | 0.22 |
Non-adherent (n=25) | 5 (20%) | 16 (64%) | 16 (64%) | 22 (88%) |
Bold values indicate significant difference between baseline and 6-month follow-up measures.